Updated Oct. 18, 2011 at 5:16 p.m.
However, the vaccine won't be available for at least three years, as crucial further testing must be completed to see how well it works in infants and how long protection lasts. Then the vaccine must be reviewed by government agencies in Europe and in individual African countries....Copyright 2013 by The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
GSK vaccine proves effective in fighting malaria
Post a comment
Print this blog postE-mail blog post
Share
However, the vaccine won't be available for at least three years, as crucial further testing must be completed to see how well it works in infants and how long protection lasts. Then the vaccine must be reviewed by government agencies in Europe and in individual African countries....Copyright 2013 by The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
Please Log In to add a comment.
Best of TechWire Insider
The Skinny
NC Biotech Center braces for worst as Senate slashes budget, too
ArchiveSocial, a new Durham success story, brings home international award
Durham's high-tech infrastructure, talent lure Virginia company
Lenovo acknowledges layoffs in Morrisville as part of shift to 'PC Plus' strategy
Raleigh-based PRA International eyes public offering
Will lightning strike again for veteran entrepreneur Brian Handly at StepLeader?
Raleigh app developer StepLeader lands $4.4M in first fund raiser
IBM opens Linux center in China, says it will work with Red Hat
Red-hot Raleigh startup WedPics hauls in $1.1M in funding
New Triangle venture capital firm slowly emerging from shadows















